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Abstract WEHI-231 and Bal 17 B cell lines are representative
models for immature and mature B cells, respectively. Their
regulation of cytosolic Ca2+ concentration ([Ca2+]c) was com-
pared using fura-2 £uorescence ratiometry. The ligation of B cell
antigen receptor (BCR) by anti-IgM antibody induced a slow
but large increase of [Ca2+]c in WEHI-231 cells while not in Bal
17 cells. The thapsigargin-induced store-operated Ca2+ entry
(SOCE) of Bal 17 cells reached a steady state which was
blocked by 2-aminoethoxydiphenyl borate (2-APB). On the con-
trary, the thapsigargin-induced SOCE of WEHI-231 cells in-
creased continuously, which was accelerated by 2-APB. The
increase of [Ca2+]c by BCR ligation was also enhanced by
2-APB in WEHI-231 cells while blocked in Bal 17 cells. The
Mn2+ quenching study showed that the thapsigargin-, or the
BCR ligation-induced Ca2+ in£ux pathway of WEHI-231 was
hardly permeable to Mn2+. The intractable increase of [Ca2+]c
may explain the mechanism of BCR-driven apoptosis of WEHI-
231 cells, a well-known model of clonal deletion of autoreactive
immature B cells.
3 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
A multitude of cellular processes are controlled through
Ca2þ signaling. Cytosolic Ca2þ concentration ([Ca2þ]c) is in-
creased either by release from Ca2þ stores, or by in£ux across
the plasma membrane. In B cells, the regulatory pathways of
[Ca2þ]c is believed to control cell proliferation, di¡erentiation
and apoptotic processes [1,2]. Cross-linking of B cell antigen
receptor (BCR) activates a series of protein tyrosine kinases
(PTKs) [3]. Several of these PTKs (e.g. Syk and Btk) are
involved in the activation of phospholipase CQ, producing
inositol 1,4,5-trisphosphate (IP3) which subsequently mobi-
lizes intracellular Ca2þ stores via IP3 receptor. The resulting
decrease in the Ca2þ content within Ca2þ stores is expected to
trigger store-operated Ca2þ entry (SOCE) and a tonic increase
of [Ca2þ]c. A low but sustained increase in [Ca2þ]c is believed
to be essential for B cell survival and proliferation and acti-
vation of transcription factors such as NFAT [4,5].
A distinctive feature of immune system is the balanced ¢ne-
tuning between the growth and the death by apoptosis. In
bone marrow, the immature B cells with membrane-bound
immunoglobulins reactive to autoantigens are arrested in the
cell cycle and eliminated through the process of apoptosis. In
contrast, the mature B-lymphocytes, once activated by speci¢c
antigens, undergo a second round of proliferation and selec-
tion in the secondary lymphoid organs to mature into memory
cells [6,7].
Bal 17 and WEHI-231 cells are representative murine B
lymphoma cell lines that re£ect the characteristics of mature
and immature B cells, respectively [8^10]. The apoptotic re-
sponse of WEHI-231 cells to BCR ligation is especially well
known, and has been investigated as a model of stimulation-
induced apoptosis of B cells at their immature stage [8^10].
Although many early signal transduction events through the
BCR have been elucidated, the biochemical events leading to
apoptosis of immature B cells are not entirely clear. Previous
studies about the underlying mechanism of apoptosis have
revealed complex signaling pathways and among them, an
unchecked increase in [Ca2þ]c may regulate several key steps
in the apoptotic pathways (e.g. caspases and calpains) of var-
ious cell types [11,12].
Here we compared the response of [Ca2þ]c to BCR ligation
and the SOCE in Bal 17 and WEHI-231 cells. With the com-
parative study, we could observe di¡erences between two cell
lines. An intractable increase in [Ca2þ]c by BCR ligation and
by SOCE may suggest a distinctive pathway of Ca2þ in£ux in
WEHI-231 cells, a well-known model of immature B cells.
2. Materials and methods
2.1. Cells and agents
WEHI-231 and Bal 17 cells were grown in 25 mM HEPES RPMI
1640 media (Gibco, Grand Island, NY, USA) supplemented with 10%
(v/v) heat-inactivated fetal bovine serum (Hyclone, Logan, UT, USA),
50 WM 2-Mercaptoethanol (Sigma, St. Louis, MO, USA), and 1%
penicillin/streptomycin (Gibco). All cells were incubated at 37‡C in
95% O2/5% CO2. The chemicals and drugs used in this study were
purchased from Sigma, and the rabbit F(ab’)2 anti-mouse IgM anti-
body from Zymed Laboratories Inc (Oxnard, CA, USA). The anti-
body was applied into the cuvette to make a ¢nal concentration of 2.5
Wg/ml.
2.2. [Ca2+]c measurement
The measurement of [Ca2þ]c was done in HEPES-bu¡ered physio-
logical salt solution (PSS) containing 145 mM NaCl, 3.6 mM KCl,
10 mM HEPES, 1.3 mM CaCl2, 1 mM MgCl2, 5 mM D-glucose and
pH was titrated to 7.4 with NaOH. Cells were harvested using
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HEPES-bu¡ered PSS, loaded with fura-2 acetoxymethyl ester (5 WM,
35 min, 37‡C), and washed twice with fresh solution. The £uorescence
was monitored in a stirred quartz-microcuvette (1 ml) in the thermo-
stated cell holder of £uorescence spectrophotometer (CAF-110, Jasco,
Japan) at the wavelengths of 340 and 380 (excitation), and 510 nm
(emission). Obtained results were calibrated by adding 10 WM iono-
mycin with 10 mM CaCl2, which gives the maximum value of £uo-
rescence ratio (340 nm/380 nm, Rmax), and 35 mM EGTA which gives
the minimum value of £uorescence ratio (Rmin). The [Ca2þ]c was cal-
culated from the equation introduced by Grynkiewicz et al. [13]. The
measured basal [Ca2þ]c was between 80 and 120 nM.
2.3. Mn2+ quenching experiment
At the isobestic wavelength of 360 nm, the fura-2 £uorescence in-
tensity is not in£uenced by [Ca2þ]c changes [13]. Mn2þ has been
shown to quench fura-2 after binding to the dye. The slope of fura-
2 £uorescence quenching trace at 360 nm in the presence of Mn2þ is
therefore regarded as an index of divalent cation in£ux [14]. Experi-
ments were carried out by adding 200 WM MnCl2 in Ca2þ-free me-
dium that excludes Ca2þ competition for the divalent cation entry
pathway and enhances the observed £uorescence quenching resulting
from Mn2þ entry. Following measurement of basal Mn2þ entry,
10 WM ionomycin was added to reveal maximum quenching, and for
the conversion of £uorescence intensity into normalized percent scale.
2.4. Data analysis and statistics
The data are presented as original recordings and bar graphs of
meanSS.E.M. When necessary, Student’s t-test was applied and
P6 0.05 was regarded as signi¢cant.
3. Results
3.1. Striking increase of [Ca2+]c upon BCR engagement in
WEHI-231 cells
After fura-2 loading, the resting [Ca2þ]c of Bal 17 and of
WEHI-231 cells were 89S 2.9 nM (n=30) and 83S2.3 nM
(n=30), respectively. In Bal 17 cells, the engagement of
BCR by anti-IgM Ab (2.5 Wg/ml) induced a transient increase
of [Ca2þ]c while WEHI-231 cells did not show a signi¢cant
immediate response (Fig. 1A, n=6 and 5, respectively).
The [Ca2þ]c responses of B cells were also compared after a
sustained BCR ligation. After loading the cells with fura-2,
anti-IgM Ab was added to 4 ml of cell suspension (about
5U105 cells/ml), incubated at 37‡C with gentle shaking
(1 cycle/s). At 15, 30, 60, and 90 min after stimulation, 1 ml
of cell suspension was sampled out and [Ca2þ]c was measured.
Experiments were repeated in ¢ve di¡erent batches of cultured
cells and the mean values of [Ca2þ]c were plotted (Fig. 2B). A
striking feature was that the sustained BCR ligation (s 30
min) of WEHI-231 cells (closed squares) induced a large in-
crease in [Ca2þ]c while the same stimulation of Bal 17 cells
(open circles) showed only a weak rise of [Ca2þ]c.
3.2. Di¡erent characteristics of thapsigargin-induced SOCE in
Bal 17 and WEHI-231 cells
In many kinds of cells including lymphocytes, a depletion of
intracellular Ca2þ stores activates SOCE pathways [15,16].
Although the BCR ligation in WEHI-231 cells did not evoke
an immediate Ca2þ response, one of plausible e¡ects of sus-
tained BCR ligation could be a slow emptying of Ca2þ stores,
and the Ca2þ in£ux induced by the store-depletion might
partly explain the increase of [Ca2þ]c in B cells. Therefore,
subsequent studies were undertaken to compare the SOCE
between Bal 17 and WEHI-231 cells. A general protocol to
prove the presence of SOCE is ‘Ca2þ-add-back procedure’ : in
the absence of extracellular Ca2þ, an inhibitor of endoplasmic
reticulum (ER) Ca2þ-ATPase or Ca2þ-releasing agonists are
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Fig. 1. E¡ects of BCR ligation on [Ca2þ]c of B cells. A: Representative traces of the [Ca2þ]c of Bal 17 (left panel) and WEHI-231 cells (right
panel) and their response to anti-IgM antibody (2.5 Wg/ml). B: Summary of the Ca2þ response to sustained stimulation with anti-IgM Ab.
MeansSS.E. of [Ca2þ]c of Bal 17 (open circles) and WEHI-231 cells (closed squares) are plotted against the duration of stimulation with anti-
IgM Ab (n=5, respectively).
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applied, then Ca2þ is added to see whether the Ca2þ in£ux
was enhanced by prior depletion of Ca2þ store [15,16].
In this experiment, ¢rstly, the extracellular Ca2þ was re-
moved by chelating with 1.5 mM EGTA and the cells were
treated with 1 WM thapsigargin which would induce a passive
leak and depletion of Ca2þ in ER via inhibiting the Ca2þ-
ATPase activity of ER. The application of thapsigargin to
cells in Ca2þ-free condition (chelated by EGTA) showed a
transient increase of [Ca2þ]c in both Bal 17 and WEHI-231
cells. On supplying extracellular CaCl2 (5 mM), [Ca2þ]c was
increased to above resting concentration in both Bal 17 and
WEHI-231 cells (Fig. 2). In Bal 17 cells, the thapsigargin-
induced SOCE (SOCETg) was suppressed by the addition of
50 WM 2-aminoethoxydiphenyl borate (2-APB; Fig. 2A)
which has been recently reported as a blocker of SOCE chan-
nel in the immune cells [17]. The blocking e¡ect of 2-APB was
more prominent when applied before the addition of CaCl2
(Fig. 2B).
Opposite to the aforementioned inhibitory e¡ect of 2-APB,
SOCETg of WEHI-231 cells was not suppressed but enhanced
by 2-APB. Fig. 2C demonstrates a representative result of the
SOCETg of WEHI-231 cells. On adding 2-APB, with some
delay, an additional increase of [Ca2þ]c was observed. The
application of 2-APB before adding CaCl2 also facilitated
the SOCETg in WEHI-231 cells. In Fig. 2D, when pretreated
with 2-APB, there appeared an intractable increase of [Ca2þ]c
which did not saturate during the time observed after the
addition of CaCl2 (s 10 min). Summarized results from ¢ve
experiments are shown as bar graphs in Fig. 2E,F.
3.3. Combined e¡ects of BCR ligation and Ca2+-add-back
procedure on [Ca2+]c
In WEHI-231 cells, more than 30 min of BCR ligation was
required to show a discernible increase in [Ca2þ]c. Interest-
ingly, when the stimulation of BCR ligation was combined
with the aforementioned ‘Ca2þ-add-back procedure’, the
Fig. 2. Thapsigargin-induced SOCE in B cells. The extracellular Ca2þ was chelated by adding 1.5 mM of EGTA (0 mM Ca2þ). The addition
of thapsigargin induced a transient increase of [Ca2þ]c in Bal 17 (A,B) and WEHI-231 cells (C,D). The addition of Ca2þ (5 mM CaCl2) in-
duced a rise of [Ca2þ]c. in both cell-line cells (SOCETg). Fifty WM 2-APB was applied either before (B,D) or after the addition of Ca2þ (A,C).
Note that SOCETg was inhibited by 2-APB treatment in Bal 17 cells while enhanced in WEHI-231 cells. Bar graphs present the summary of
the Ca2þ responses to experimental protocols shown in A and C (graph E), and in B and D (graph F). Open bars, Bal 17 (meanSS.E., n=5);
closed bars, WEHI-231 (meanSS.E., n=5). In E and F, the mean values of initial [Ca2þ]c before the addition of EGTA are also shown (con-
trol). Numbers and small letters in parentheses indicate the timing of [Ca2þ]c measurement (see downward arrows in the original traces above).
Asterisks indicate statistically signi¢cant di¡erence (P6 0.05).
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Ca2þ response of WEHI-231 cells was accelerated. For this
experiment, after chelating extracellular Ca2þ with 1.5 mM
EGTA, cells were stimulated with anti-IgM Ab for six min
and then 5 mM CaCl2 was added (Fig. 3).
In Bal 17 cells, the application of anti-IgM Ab induced a
transient increase of [Ca2þ]c, which we interpreted as the re-
lease of stored calcium ions (Fig. 4A,B). In this condition, the
response of [Ca2þ]c to re-addition of CaCl2 was considered as
re£ecting the SOCE induced by BCR cross-linking (SOCEBCR).
The SOCEBCR of Bal 17 cells was inhibited, although not com-
pletely, by the application of 2-APB (Fig. 3A). The inhibition
of SOCEBCR appeared more e¡ective when 2-APB was applied
before the addition of CaCl2 (Fig. 3B).
In WEHI-231 cells, the immediate Ca2þ response to BCR
ligation was negligible and the initial increase of [Ca2þ]c on
adding CaCl2 was smaller than that of Bal 17 cells. However,
the combined stimulation of BCR ligation and Ca2þ-add-back
procedure increased the [Ca2þ]c of WEHI-231 cells continu-
ously, which was not blocked, or even slightly accelerated by
the addition of 2-APB (Fig. 3C). The pretreatment with
2-APB unequivocally facilitated the aforementioned combined
e¡ects in WEHI-231 cells ; a slow, but intractable increase of
[Ca2þ]c appeared on adding CaCl2 after the application of
2-APB, which did not saturate during the time of experiment
(Fig. 3D). Summarized results are shown as bar graphs in Fig.
3E,F.
In Figs. 2 and 3, the initial rate of Ca2þ increase on adding
CaCl2 seemed lower in WEHI-231 cells than in Bal 17 cells.
To compare this, [Ca2þ]c was measured during the initial 15 s
after the addition of CaCl2, then the slope of Ca2þ increase
was calculated. In Bal 17 cells, the initial rates of Ca2þ in-
crease were 12.8 S 1.83 and 11.1 S 1.44 nM/s when stimulated
with thapsigargin and BCR ligation, respectively (n=5). In
contrast, the corresponding rates of WEHI-231 cells were
4.7 S 0.74 and 2.2S 0.26 nM/s, when stimulated with thapsi-
gargin and BCR ligation, respectively (n=5).
3.4. The low Mn2+ permeability of SOCE pathway in
WEHI-231 cells
Mn2þ ions reportedly permeate SOCE channels, and the
Fig. 3. Combined e¡ects of BCR ligation and Ca2þ-add-back procedure in B cells. The extracellular Ca2þ was chelated by adding 1.5 mM of
EGTA from the initial control. The application of antibody (anti-IgM) induced a transient increase of [Ca2þ]c in Bal 17 (A,B) while not in
WEHI-231 (C,D). The addition of Ca2þ (5 mM CaCl2) induced a rise of [Ca2þ]c in both cell lines. Fifty WM of 2-APB was applied either be-
fore (B,D), or after the re-addition of Ca2þ (A,C). Note the 2-APB-induced augmentation of Ca2þ response in WEHI-231 (C,D). Bar graphs
present the summary of the Ca2þ responses to experimental protocols shown in A and C (graph E), and in B and D (graph F). Open bars, Bal
17 (meanSS.E., n=5); closed bars, WEHI-231 (meanSS.E., n=5). The timing of each measurement is indicated as downward arrows with
numbers or with small letters in the original traces above. Asterisks indicate statistically signi¢cant di¡erence (P6 0.05).
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Mn2þ-induced decay of fura-2 £uorescence has been regarded
as an indicator of SOCE activity [14]. Here the £uorescence
intensity of fura-2 excited by the wavelength of 360 nm (F360)
was normalized to the initial value measured at the timing of
Mn2þ application (%F360). Fig. 4A,B presents representative
traces of Mn2þ quenching study where both cell lines were
stimulated by BCR ligation before the addition of MnCl2.
The rate of %F360 decay was signi¢cantly increased by the
application of thapsigargin or by BCR ligation in Bal 17 cells.
The pretreatment with 2-APB blocked the e¡ects of both
agents on the rate of Mn2þ in£ux (Fig. 4).
Compared with Bal 17 cells, the background in£ux of Mn2þ
was weak in WEHI-231 cells (Fig. 4, note di¡erent scales of
vertical axis in Fig. 4C^F). Moreover, the e¡ects of thapsigar-
gin or BCR ligation on Mn2þ in£ux were statistically insig-
ni¢cant (Ps 0.05, Fig. 4E,F, n=5). The inhibitory e¡ect of
2-APB was, however, still observed under conditions inducing
SOCEBCR (Fig. 4F).
4. Discussion
In this study, we demonstrated that the BCR engagement of
WEHI-231 cells induced an intractable increase of [Ca2þ]c.
Comparing the SOCE of Bal 17 and WEHI-231 cell lines,
there were striking di¡erences in their responses to a pharma-
cological agent (2-APB) which was previously reported as a
blocker of SOCE channels [17].
Membrane immunoglobulin BCRs mediate a wide variety
of biochemical signals such as the tyrosine phosphorylation,
acceleration of phosphoinositol metabolism, increase of
[Ca2þ]c, and protein kinase C activation [1^3]. B cells demon-
strate quite di¡erent cellular responses to the same kind of
BCR engagement depending on their developmental stage,
and the underlying signal transduction pathways between im-
mature and mature B cells have attracted many researchers.
Most of those studies have focused on the pattern of protein
phosphorylation, involvement of lipid rafts and related signal-
ing proteins whereas the knowledge of di¡erences in the Ca2þ
response has been limited [6,8,18^20].
The WEHI-231 lymphoma cells have been extensively
studied as an example of an immature B cell line that under-
goes growth arrest and apoptosis in response to membrane
IgM cross-linking [8^10]. Recently it was shown that calpain,
a Ca2þ-dependent protease, was speci¢cally associated with
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Fig. 4. Mn2þ in£ux in Bal 17 and WEHI-231 cells. A,B: Relative intensity of fura-2 £uorescence excited by isobestic wavelength of light (360
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ence (P6 0.05).
FEBS 26913 17-1-03
J.H. Nam et al./FEBS Letters 535 (2003) 113^118 117
BCR-induced apoptosis of WEHI-231 cells [21]. In another
report, a variant cell line of WEHI-231 cells that was resistant
to the apoptotic BCR stimulation showed a reduced Ca2þ
response compared with control WEHI-231 cells [10]. Our
present data newly demonstrate that the sustained stimulation
of BCR (s 30 min) elicits prominent increase of [Ca2þ]c in
WEHI-231 cells, which is never observed in Bal 17 cells, a
model of mature B cells (Fig. 1). However, since the present
study was con¢ned to a single kind of cell line representing
each stage of development, it should be considered with cau-
tion to directly extrapolate our results to the natural B cells in
bone marrow.
In WEHI-231 cells, although the immediate Ca2þ response
to BCR ligation was very small or indistinguishable, the sus-
tained Ca2þ response appeared to be accelerated by combined
application of ‘Ca2þ-add-back procedure’ (Fig. 3C). At
present, it is not clear whether the stimulation of BCRs in
WEHI-231 cells could induce Ca2þ in£ux simply by emptying
intracellular Ca2þ stores or by recruiting other co-operative
mechanism(s) as well. In that respect, it was notable that the
Ca2þ response to BCR ligation was more prominent than
SOCETg in WEHI-231 cells (compare Figs. 2 and 3). An in-
triguing interpretation might be that the intracellular event
accompanying the SOCE might have augmented the original
Ca2þ response to BCR engagement, or vice versa.
Another striking di¡erence between WEHI-231 and Bal 17
cells was the opposite e¡ects of 2-APB on the SOCE. 2-APB
was originally described as a non-competitive antagonist of
the IP3 receptor, and the inhibition of SOCE by 2-APB has
been taken as an evidence for the hypothesis of conforma-
tional coupling between store-operated channels and IP3 re-
ceptors [16]. However, more recent works commonly suggest
that 2-APB directly blocks the SOCE of various immune cells
independent of the IP3 receptor [17,22]. An opposite sensitiv-
ity of SOCE to 2-APB between two cell lines supports the
hypothesis that di¡erent types of Ca2þ-permeable channels
are expressed in WEHI-231 and Bal 17 cells.
In addition to the blocking e¡ect of SOCE, 2-APB exerts an
inhibitory e¡ect on the Ca2þ-ATPase of endoplasmic reticu-
lum (SERCA) [23]. Since the inhibition of SERCA could be
di¡erent depending on the isoforms of SERCA expressed, one
cannot exclude the possibility that the SERCA of WEHI-231
cells might have been more strongly inhibited by 2-APB.
However, the facilitating e¡ect of 2-APB was similarly ob-
served under the pretreatment with thapsigargin, a well-
known SERCA blocker (Fig. 2), indicating that an action
mechanism of 2-APB other than SERCA inhibition was re-
quested to explain the Ca2þ responses in WEHI-231 cells.
Moreover, the inhibition of SERCA by 2-APB occurs at high-
er concentrations (IC50s 300 WM) [23] than used in this study
(50 WM).
Although 2-APB has facilitatory e¡ects on the SOCE of
WEHI-231 cells, it was not successful to demonstrate corre-
sponding results in the Mn2þ in£ux experiment (Fig. 4). Re-
cently, it was reported that physiological stimuli of human
neutrophil recruit diverse SOCE pathways with di¡erential
sensitivity to 2-APB and with di¡erent permeabilities to diva-
lent cations [24]. In a similar context, the major Ca2þ in£ux
channels activated by BCR engagement in WEHI-231 cells
might be practically impermeable to Mn2þ, which impaired
the assessment of channel activity with the Mn2þ-quenching
method. Interestingly, the minute Mn2þ-permeable divalent
cation pathway of WEHI-231 cells was inhibited by 2-APB
(Fig. 4), indicating that multiple Ca2þ in£ux pathways might
exist in tested cells.
In summary, by comparing the change of [Ca2þ]c between
Bal 17 and WEHI-231 B lymphoma cells, we demonstrated an
obvious di¡erence in the responses elicited by BCR ligation.
Since the process of apoptosis could be triggered or reinforced
by the tonic increase of [Ca2þ]c, our ¢ndings may provide an
explanation about the mechanism for the BCR-mediated ap-
optosis of WEHI-231 cells.
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